Medication
Imovane
DIN 01926799 · Sanofi-Aventis Canada Inc
What it is
- Active ingredients
- Zopiclone — 7.5 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 1990-12-31
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Apo-Zopiclone
- PMS-Zopiclone
- Teva-Zopiclone
- Riva-Zopiclone
- Zopiclone
- Pro-Zopiclone
- Zopiclone
- Mar-Zopiclone
- Mint-Zopiclone
- Jamp-Zopiclone Tablets
- M-Zopiclone
- Alta-Zopiclone
- AG-Zopiclone
- Nra-Zopiclone
- Bio-Zopiclone
- Jamp Zopiclone
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Ontario Drug Benefit coverage
As of 31 July 2026Off-formulary interchangeable Part III-B
Ontario has designated this product interchangeable with a brand product, but it is not an ODB benefit — Part III-B, Off-Formulary Interchangeable. Ontario does not pay for it under the benefit list.
It may be funded through the Exceptional Access Program, which needs a patient-specific application from a prescriber and is decided case by case.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 7.5mg Tab and will substitute one for another at a pharmacy counter in Ontario.
- AG-Zopiclone 02475847Angita Pharma Inc.
- Apo-Zopiclone 02218313Apotex Inc
- Jamp Zopiclone 02549301Jamp Pharma Corporation
- Jamp-Zopiclone Tablets 02406977Jamp Pharma Corporation
- M-Zopiclone 02467968Mantra Pharma Inc
- Mar-Zopiclone 02386798Marcan Pharmaceuticals Inc
- Mint-Zopiclone 02391724Mint Pharmaceuticals Inc
- Nra-Zopiclone 02477386Nora Pharma Inc
- PMS-Zopiclone 02240606Pharmascience Inc
- Riva-Zopiclone 02278049Laboratoire Riva Inc.
- Teva-Zopiclone 02242481Teva Canada Limited
- Zopiclone 02282445Sanis Health Inc
- Zopiclone 02385848Sivem Pharmaceuticals ULC
Ontario lists 5 further products in this group that are not currently marketed in Canada. They are not shown.
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N05CF01
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N05CF01, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.